Total Holdings
59
Portfolio diversification across 59 positions
GNMX
(BATS)Corgi Genomics & Precision Medicine ETF
$34.15-- (--)
Loading... - Market loading
GNMX ETF Holdings: Corgi Genomics & Precision Medicine ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$1.63M
Total fund assets
Expense Ratio
0.35%
Annual management fee
Fund Issuer
Corgi
BATS
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 25 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Thermo Fisher Scientific Inc. | Stock | 9.12% |
| 2 |  | Vertex Pharmaceuticals Incorporated | Stock | 6.71% |
| 3 |  | Illumina, Inc. | Stock | 4.31% |
| 4 |  | Guardant Health, Inc. | Stock | 3.89% |
| 5 |  | Revolution Medicines, Inc. | Stock | 3.89% |
| 6 |  | Alnylam Pharmaceuticals, Inc | Stock | 3.88% |
| 7 |  | Moderna, Inc | Stock | 3.74% |
| 8 |  | Incyte Corporation | Stock | 3.25% |
| 9 | M MUTF:FGXXX | First American Government Obligations Fund Class X | Stock | 3.20% |
| 10 |  | Genmab A/S | Stock | 2.94% |
| 11 |  | Bio-Techne Corporation | Stock | 2.62% |
| 12 |  | 10x Genomics, Inc. | Stock | 2.59% |
| 13 |  | BioMarin Pharmaceutical Inc. | Stock | 2.46% |
| 14 |  | Arrowhead Pharmaceuticals, Inc. | Stock | 2.36% |
| 15 |  | Krystal Biotech, Inc. | Stock | 2.17% |
| 16 |  | Qiagen N.V. | Stock | 2.15% |
| 17 |  | Veracyte, Inc. | Stock | 2.04% |
| 18 |  | Twist Bioscience Corporation | Stock | 1.90% |
| 19 |  | Ionis Pharmaceuticals, Inc. | Stock | 1.78% |
| 20 |  | uniQure N.V. | Stock | 1.78% |
| 21 |  | Adaptive Biotechnologies Corporation | Stock | 1.75% |
| 22 |  | IDEAYA Biosciences, Inc. | Stock | 1.49% |
| 23 |  | CRISPR Therapeutics AG | Stock | 1.48% |
| 24 |  | Tempus AI, Inc. | Stock | 1.44% |
| 25 |  | Nurix Therapeutics, Inc. | Stock | 1.42% |
Frequently Asked Questions About Corgi Genomics & Precision Medicine ETF Holdings
What are the top holdings in GNMX?
Corgi Genomics & Precision Medicine ETF (GNMX) holds 59 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is GNMX's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review GNMX's holdings table to analyze concentration risk.
What is GNMX's sector allocation?
The Sector Allocation chart shows how GNMX distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does GNMX invest in?
GNMX's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is GNMX ETF?
GNMX's diversification can be assessed by reviewing its 59 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.